These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 4999365)

  • 1. The Australian rifampicin trial.
    Proust AJ
    Med J Aust; 1971 Jul; 2(2):85-94. PubMed ID: 4999365
    [No Abstract]   [Full Text] [Related]  

  • 2. Rifampin in initial treatment of pulmonary tuberculosis. A U.S. Public Health Service tuberculosis therapy trial.
    Newman R; Doster B; Murray FJ; Ferebee S
    Am Rev Respir Dis; 1971 Apr; 103(4):461-76. PubMed ID: 4994459
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatotoxicity in rifampin-isoniazid treated patients related to their rate of isoniazid inactivation.
    Smith J; Tyrell WF; Gow A; Allan GW; Lees AW
    Chest; 1972 Jun; 61(6):587-8. PubMed ID: 5032153
    [No Abstract]   [Full Text] [Related]  

  • 4. Intermittent therapy with rifampin once a week in advanced pulmonary tuberculosis.
    Verbist L; Mbete S; Van Landuyt H; Darras T; Gyselen A
    Chest; 1972 Jun; 61(6):555-63. PubMed ID: 4624278
    [No Abstract]   [Full Text] [Related]  

  • 5. Isoniazid plus rifampicin in the initial treatment of pulmonary tuberculosis.
    Clarke GB; Cuthbert J; Cuthbert RJ; Lees AW
    Br J Dis Chest; 1972 Oct; 66(4):268-71. PubMed ID: 5083434
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum enzyme changes in patients receiving antituberculosis therapy with rifampicin or p-aminosalicylic acid, plus isoniazid and streptomycin.
    Baron DN; Bell JL
    Tubercle; 1974 Jun; 55(2):115-20. PubMed ID: 4620296
    [No Abstract]   [Full Text] [Related]  

  • 7. Controlled trial of intermittent regimens of rifampin plus isoniazid for pulmonary tuberculosis in Singapore. The results up to 30 months.
    Am Rev Respir Dis; 1977 Nov; 116(5):807-20. PubMed ID: 411405
    [No Abstract]   [Full Text] [Related]  

  • 8. [Liver toxicity of combined rifampicin-isoniazid-ethambutol medication (author's transl)].
    Austerhoff A; Kindler U; Knop P; Knieriem HJ
    Dtsch Med Wochenschr; 1974 May; 99(22):1182 p. PubMed ID: 4835559
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacodynamic interference between rifampicin and isoniazid.
    Llorens J; Serrano RJ; Sanchez R
    Chemotherapy; 1978; 24(2):97-103. PubMed ID: 620612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
    Mkrtchian SV; Ushkin VV
    Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rifampicin and liver].
    Chevrel B
    Presse Med (1893); 1971 Oct; 79(43):1911-2. PubMed ID: 5128490
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood levels of rifampicin in liver diseases.
    Pozzi E; Menghini P
    Int J Clin Pharmacol; 1974 Jul; 10(1):44-9. PubMed ID: 4850803
    [No Abstract]   [Full Text] [Related]  

  • 13. Jaundice after rifampicin.
    Lees AW; Asgher B; Hashem MA; Sinha BN
    Br J Dis Chest; 1970 Apr; 64(2):90-5. PubMed ID: 5432630
    [No Abstract]   [Full Text] [Related]  

  • 14. Rifampin in treatment of advanced pulmonary tuberculosis. Report of a VA cooperative pilot study.
    Raleigh JW
    Am Rev Respir Dis; 1972 Mar; 105(3):397-409. PubMed ID: 5011668
    [No Abstract]   [Full Text] [Related]  

  • 15. Rifampin and isoniazid in previously untreated patients with pulmonary tuberculosis.
    Lees AW; Allan GW; Smith J; Tyrrell WF; Fallon RJ
    Am Rev Respir Dis; 1972 Jan; 105(1):132-4. PubMed ID: 5007611
    [No Abstract]   [Full Text] [Related]  

  • 16. Rifampicin.
    Polascik M; Golden B
    Ann Ophthalmol; 1971 Aug; 3(8):877-82. PubMed ID: 5005929
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological study of rifampicin after repeated high dosage during intermittent combined therapy. II. Bilirubin levels and other biochemical determinations.
    Verbist L; Rollier F
    Respiration; 1971; 28():Suppl:17-28. PubMed ID: 5150793
    [No Abstract]   [Full Text] [Related]  

  • 18. Late results following rifampicin therapy and tolerance of rifampicin given on a long-term basis.
    Flemming J; Virchow C
    Respiration; 1971; 28():Suppl:107-15. PubMed ID: 5150790
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rifampicin and its clinical use].
    Fafrowicz B
    Wiad Lek; 1971 Jul; 24(3):233-8. PubMed ID: 4926926
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of meals on rifampicin absorption.
    Siegler DI; Bryant M; Burley DM; Citron KM; Standen SM
    Lancet; 1974 Jul; 2(7874):197-8. PubMed ID: 4135611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.